leucine has been researched along with Anti-Phospholipid Antibody Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S; Terashi, H; Uchiyama, S | 1 |
| Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D | 1 |
| Cervera, R; Chamorro, AJ; Espinosa, G; Marcos, M; Mirón-Canelo, JA | 1 |
| Choi, SJ; Ji, JD; Lee, YH; Song, GG | 1 |
| Diz-Kucukkaya, R; Hancer, VS; Inanc, M; Nalcaci, M; Pekcelen, Y | 1 |
| Atsumi, T; Ichikawa, K; Kaihara, K; Koike, T; Matsuura, E; Yamamoto, D; Yasuda, S | 1 |
| Dziedzina, S; Iwaniec, T; Musiał, J; Sanak, M; Swadzba, J | 1 |
3 review(s) available for leucine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
[Beta2-glycoprotein I polymorphism].
Topics: Adult; Alleles; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; beta 2-Glycoprotein I; beta-Thromboglobulin; Female; Genotype; Humans; Leucine; Male; Middle Aged; Platelet Factor 4; Polymorphism, Genetic; Risk Factors; Stroke; Valine | 2008 |
Val247Leu β2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis.
Topics: Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Gene Frequency; Genetic Variation; Genotype; Humans; Leucine; Polymorphism, Genetic; Valine | 2012 |
Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis.
Topics: Alleles; Antibodies; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Genetic Predisposition to Disease; Humans; Leucine; Polymorphism, Genetic; Thrombosis; Valine | 2012 |
4 other study(ies) available for leucine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine | 2009 |
Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Factor XIII; Female; Gene Frequency; Genotype; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Venous Thrombosis | 2004 |
Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
Topics: Adult; Aged; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Female; Glycoproteins; Humans; Leucine; Male; Middle Aged; Molecular Conformation; Polymorphism, Genetic; Valine | 2005 |
Valine/Leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies.
Topics: Adult; Aged; Aged, 80 and over; Antiphospholipid Syndrome; Autoimmune Diseases; beta 2-Glycoprotein I; Case-Control Studies; Female; Glycoproteins; Humans; Leucine; Male; Middle Aged; Poland; Polymorphism, Single Nucleotide; Valine | 2006 |